When patients are forced to undergo a total pancreatectomy they develop diabetes from losing insulin producing cells. A partnership between a Pittsburgh-based pharmaceutical company and West Virginia University Health Systems is seeking to address this.
Imagine Pharma selected by WVU Health System to provide services to pancreatectomy patients – The TechLead
![](https://techlead.co.in/wp-content/uploads/2024/05/dsc3949-1100xx1796-1804-0-586.png)